Announced Wed, 20 May · 18:59 IST

Pursuant to Regulations 30, 33 and other applicable regulations of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform that the Board of Directors ....

Revenue Growth 20pctPat Growth 25pctResults View source PDF

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-1.0%1-day move
₹103.10
prior close
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-1.0+4.0+9.2+9.6+9.4+7.5+15.4+16.0
Up moveDown movePending
AI summary

Gujarat Inject Kerala Ltd reported strong audited standalone results for FY2025-26. Revenue from operations grew 91% to ₹3,632.04 Lakhs from ₹1,904.58 Lakhs in the previous year. Profit after tax surged 78% to ₹181.41 Lakhs from ₹101.72 Lakhs, while EPS improved to ₹1.24 from ₹0.70. The company generated positive operating cash flow of ₹2,122.01 Lakhs compared to negative ₹352.20 Lakhs in the prior year. Statutory auditors M/s S. Mandawat & Co. issued an unmodified (clean) audit opinion on the financial statements. The Board meeting was held on May 20, 2026.

Likely market impact

The company demonstrated exceptional revenue and profit growth with significant improvement in cash generation, signaling strong operational performance. Shareholders may view this positively given the clean audit opinion and turnaround in cash flows.